Get started
Work

The B2M–LILRB1 axis as a novel myeloid immune checkpoint and therapeutic target in multiple myeloma

Year: 2025
Type: conference-abstract
Source: Blood
DOI: 10.1182/blood-2025-1032
Authors: Marcello Turi, Pietro Folino, Francesca Barello, Tallya Maciel, Selma Cifric, Paola Rampa, Mehmet Samur, Giovanni De Nola, Rita Starace, Vanessa Favasuli, Alessandro Salatino, Sofia Pasparaki, Carlo Campa, Delaney Vinaixa, Cole Clericuzio, Priya Thurman, Megan Johnstone, Francesca Bonello, Abigail Lytton-Jean, Cirino Botta, Eugenio Morelli, Nikhil Munshi, Kenneth Anderson, Annamaria Gulla
Institutions: Candiolo Cancer Institute, Dana-Farber Cancer Institute, Koch Institute for Integrative Cancer Research At MIT, Massachusetts Institute of Technology, Italian institute for Genomic Medicine, University of Palermo
Language: English
Subfield: Hematology
Field: Medicine
Open Access status: closed
OpenAlex ID: W4417004893
Cites:
Cited by:
Related to: